Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Pneumocystis jirovecii pneumonia in everolimus-treated renal cell carcinoma.

Authors:
Marie-Charlotte Loron Steven Grange Dominique Guerrot Frédéric Di Fiore Caroline Freguin Mélanie Hanoy Frank Le Roy Gwenaelle Poussard Isabelle Etienne Bruno Legallicier Christian Pfister Michel Godin Dominique Bertrand

J Clin Oncol 2015 Mar 17;33(8):e45-7. Epub 2014 Mar 17.

Rouen University Hospital, Rouen, France.

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.9277DOI Listing
March 2015

Publication Analysis

Top Keywords

renal cell
4
cell carcinoma
4
everolimus-treated renal
4
pneumonia everolimus-treated
4
pneumocystis jirovecii
4
jirovecii pneumonia
4
carcinoma
1
pneumocystis
1
pneumonia
1
cell
1
everolimus-treated
1
renal
1

Similar Publications

Extracellular Vesicles and Renal Endothelial Cells: a Fatal Attraction in Hemolytic Uremic Syndrome.

Authors:
Elisa Varrone Domenica Carnicelli Maurizio Brigotti

Am J Pathol 2021 Feb 27. Epub 2021 Feb 27.

Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, University of Bologna, Bologna, Italy. Electronic address:

This review will focus on typical hemolytic uremic syndrome (HUS), a life-threatening sequela of human infections caused, particularly in children, by Shiga toxin-producing Escherichia coli strains (STEC). Thrombotic microangiopathy of the brain and the kidney is the endpoint of toxin action resulting in the hallmarks of HUS, i.e. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Cell-free DNA maps COVID-19 tissue injury and risk of death, and can cause tissue injury.

Authors:
Temesgen E Andargie Naoko Tsuji Fayaz Seifuddin Moon Kyoo Jang Peter St Yuen Hyesik Kong Ilker Tunc Komudi Singh Ananth Charya Kenneth J Wilkins Steven D Nathan Andrea L Cox Mehdi Pirooznia Robert A Star Sean Agbor-Enoh

JCI Insight 2021 Mar 2. Epub 2021 Mar 2.

Genomic Research Alliance for Transplantation (GRAfT), National Heart, Lung, and Blood Institute (NHLBI), Bethesda, United States of America.

Introduction: Coronavirus 2019 (COVID-19) clinical course is heterogeneous, ranging from mild to severe multi-organ failure and death. In this study, we analyzed cell-free DNA (cfDNA) as a biomarker of injury to define the sources of tissue injury that contribute to such different trajectories.

Methods: We conducted a multi-center prospective cohort study to enroll COVID-19 patients and collect plasma samples. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction.

Authors:
Rebecca J Woolley Daan Ceelen Wouter Ouwerkerk Jasper Tromp Sylwia M Figarska Stefan D Anker Kenneth Dickstein Gerasimos Filippatos Faiez Zannad Metra Marco Leong Ng Nilesh Samani Dirk van Veldhuisen Chim Lang Carolyn S Lam Adriaan Voors

Eur J Heart Fail 2021 Mar 2. Epub 2021 Mar 2.

Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

Aims: The lack of effective therapies for patients with heart failure with preserved ejection fraction (HFpEF) is often ascribed to the heterogeneity of patients with HFpEF. We aimed to identify distinct pathophysiologic clusters of HFpEF based on circulating biomarkers.

Methods And Results: We performed an unsupervised cluster analysis using 363 biomarkers from 429 patient with HFpEF. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap